Literature DB >> 34233490

Evaluation of foot hypoperfusion and estimation of percutaneous transluminal angioplasty outcome in patients with critical limb ischemia using intravoxel incoherent motion microperfusion MRI.

Nikolaos Galanakis1, Thomas G Maris2, Georgios Kalaitzakis2, Nikolaos Kontopodis3, Nikolas Matthaiou1, Stavros Charalambous1, Konstantinos Tsetis1, Christos V Ioannou3, Apostolos Karantanas1, Dimitrios Tsetis1.   

Abstract

OBJECTIVES: To emerge hypoperfusion of lower limbs in patients with critical limb ischemia (CLI) using Intravoxel Incoherent Motion microperfusion magnetic resonance imaging (IVIM-MRI). Moreover to examine the ability of IVIM-MRI to differentiate patients with severe peripheral arterial disease (PAD) from normal subjects and evaluate the percutaneous transluminal angioplasty (PTA) results in patients with CLI.
METHODS: Eight patients who presented with CLI and six healthy volunteers were examined. The patients underwent IVIM-MRI of lower extremity before and following PTA. The imaging protocol included sagittal diffusion-weighted (DW) sequences. DW images were analyzed and color parametric maps of the micro-circulation of blood inside the capillary network (D*) were constructed. The studies were evaluated by two observers to define interobserver reproducibility.
RESULTS: Technical success was achieved in all patients (8/8). The mean ankle-brachial index increased from 0.35 ± 0.2 to 0.76 ± 0.25 (p < 0.05). Successful revascularization improved IVIM microperfusion. Mean D* increased from 279.88 ± 13.47 10-5 mm2/s to 331.51 ± 31 10-5 mm2/s, following PTA, p < 0.05. Moreover, PAD patients presented lower D* values as compared to healthy individuals (279.88 ± 13.47 10-5 mm2/s vs 332.47 ± 22.95 10-5 mm2/s, p < 0.05, respectively). Good interobserver agreement was obtained with an ICC = 0.84 (95% CI 0.64-0.93).
CONCLUSIONS: IVIM-MRI can detect differences in microperfusion between patients with PAD and healthy individuals. Moreover, significant restitution of IVIM microperfusion is found following successful PTA. ADVANCES IN KNOWLEDGE: IVIM-MRI is a safe, reproducible and effective modality for evaluation of lower limb hypoperfusion in patients with PAD. It seems also to be a helpful tool to detect changes of tissue perfusion in patients with CLI following revascularization.

Entities:  

Mesh:

Year:  2021        PMID: 34233490      PMCID: PMC9327774          DOI: 10.1259/bjr.20210215

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  32 in total

1.  Laser Doppler imaging in the investigation of lower limb wounds.

Authors:  Faisel Khan; David J Newton
Journal:  Int J Low Extrem Wounds       Date:  2003-06       Impact factor: 2.057

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

3.  IVIM improves preoperative assessment of microvascular invasion in HCC.

Authors:  Yi Wei; Zixing Huang; Hehan Tang; Liping Deng; Yuan Yuan; Jiaxing Li; Dongbo Wu; Xiaocheng Wei; Bin Song
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

4.  CT Foot Perfusion Examination for Evaluation of Percutaneous Transluminal Angioplasty Outcome in Patients with Critical Limb Ischemia: A Feasibility Study.

Authors:  Nikolaos Galanakis; Thomas G Maris; Nikolaos Kontopodis; Christos V Ioannou; Elias Kehagias; Nikolas Matthaiou; Antonios E Papadakis; Adam Hatzidakis; Konstantinos Perisinakis; Dimitrios Tsetis
Journal:  J Vasc Interv Radiol       Date:  2019-04       Impact factor: 3.464

5.  Dynamic Volume Perfusion CT of the Foot in Critical Limb Ischemia: Response to Percutaneous Revascularization.

Authors:  Emetullah Cindil; Gonca Erbas; Koray Akkan; Mahi Nur Cerit; Halit Nahit Sendur; Mustafa Hakan Zor; Erhan Ilgıt
Journal:  AJR Am J Roentgenol       Date:  2020-02-25       Impact factor: 3.959

6.  Effects of percutaneous transluminal angioplasty on muscle BOLD-MRI in patients with peripheral arterial occlusive disease: preliminary results.

Authors:  Rolf W Huegli; Anja-Carina Schulte; Markus Aschwanden; Christoph Thalhammer; Sebastian Kos; Augustinus L Jacob; Deniz Bilecen
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

7.  IVIM perfusion fraction is prognostic for survival in brain glioma.

Authors:  Christian Federau; Milena Cerny; Marion Roux; Pascal J Mosimann; Philippe Maeder; Reto Meuli; Max Wintermark
Journal:  Clin Neuroradiol       Date:  2016-04-26       Impact factor: 3.649

8.  Apparent diffusion coefficient measurements on a novel diffusion weighted MRI phantom utilizing EPI and HASTE sequences.

Authors:  Georgios Kalaitzakis; Themistoklis Boursianis; Georgios Gourzoulidis; Sofia Gourtsoyianni; Georgia Lymperopoulou; Konstantinos Marias; Apostolos Karantanas; Thomas G Maris
Journal:  Phys Med       Date:  2020-05-01       Impact factor: 2.685

9.  Utility of intravoxel incoherent motion magnetic resonance imaging and arterial spin labeling for recurrent glioma after bevacizumab treatment.

Authors:  Fuminori Miyoshi; Yuki Shinohara; Atsushi Kambe; Keita Kuya; Atsushi Murakami; Masamichi Kurosaki; Toshihide Ogawa
Journal:  Acta Radiol       Date:  2018-02-22       Impact factor: 1.990

10.  Evaluation of skeletal muscle microvascular perfusion of lower extremities by cardiovascular magnetic resonance arterial spin labeling, blood oxygenation level-dependent, and intravoxel incoherent motion techniques.

Authors:  Shiteng Suo; Lan Zhang; Hui Tang; Qihong Ni; Suqin Li; Haimin Mao; Xiangyu Liu; Shengyun He; Jianxun Qu; Qing Lu; Jianrong Xu
Journal:  J Cardiovasc Magn Reson       Date:  2018-03-19       Impact factor: 5.364

View more
  1 in total

1.  Improvement in local vascular perfusion of the lower extremities on intravoxel incoherent motion imaging: A case report.

Authors:  Mitsunari Maruyama; Hiroya Aso; Hisatoshi Araki; Rika Yoshida; Shinji Ando; Megumi Nakamura; Takeshi Yoshizako
Journal:  Radiol Case Rep       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.